Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Vaccines”

2,069 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,069 results

Not applicableNot Yet RecruitingNCT07525024
What this trial is testing

KSD-101 in Patients With EBV-associated Hematological Malignancies

Who this might be right for
EBV Associated Lymphoid Neoplasms
Ruijin Hospital 80
Very early researchStudy completedNCT04936997
What this trial is testing

Immune Response to the COVID-19 Vaccine

Who this might be right for
Covid19CancerMalignancy+1 more
University of Arizona 20
Testing effectiveness (Phase 2)Looking for participantsNCT06636682
What this trial is testing

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate CAProstate Cancers+4 more
Cellvax Therapeutics Inc 100
Testing effectiveness (Phase 2)Ended earlyNCT02010203
What this trial is testing

HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT

Who this might be right for
Bladder Cancer
Heat Biologics 104
Early research (Phase 1)Study completedNCT04116710
What this trial is testing

HS130 in Combination With Viagenpumatucel-L (HS110) in Patients With Solid Tumors

Who this might be right for
Advanced Solid Tumor
Heat Biologics 15
Testing effectiveness (Phase 2)Study completedNCT02648282
What this trial is testing

Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 58
Early research (Phase 1)Study completedNCT00988559
What this trial is testing

Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)

Who this might be right for
HPV16 PositiveCervical Intraepithelial Neoplasia (CIN 2/3)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 132
Early research (Phase 1)Study completedNCT01634503
What this trial is testing

Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3

Who this might be right for
Cervical Intraepithelial Neoplasia 3
Genexine, Inc. 9
Large-scale testing (Phase 3)Active Not RecruitingNCT05285826
What this trial is testing

Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 8,100
Not applicableStudy completedNCT00889278
What this trial is testing

Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation

Who this might be right for
Lymphoma
Dartmouth-Hitchcock Medical Center 30
Not applicableEnded earlyNCT03701438
What this trial is testing

Immune Response to Influenza Vaccine in Adults With B-cell Malignancies Treated With Idelalisib

Who this might be right for
B-cell Malignancies
Gilead Sciences 2
Testing effectiveness (Phase 2)Study completedNCT00003125
What this trial is testing

Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors

Who this might be right for
Breast CancerEsophageal CancerGastric Cancer+3 more
Georgetown University 24
Large-scale testing (Phase 3)Study completedNCT00996125
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Human Papillomavirus 580299 Vaccine in Healthy Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 750
Testing effectiveness (Phase 2)Looking for participantsNCT05127824
What this trial is testing

Autologous Dendritic Cell Vaccine in Kidney Cancer

Who this might be right for
Carcinoma, Renal Cell
Jodi Maranchie 42
Testing effectiveness (Phase 2)Ended earlyNCT01353222
What this trial is testing

DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Dendreon 142
Testing effectiveness (Phase 2)Study completedNCT00020475
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye

Who this might be right for
Extraocular Extension MelanomaRecurrent Intraocular Melanoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT02385669
What this trial is testing

A Phase I/II Trial to Evaluate a Peptide Vaccine Plus Ipilimumab in Patients With Melanoma

Who this might be right for
Melanoma
Craig L Slingluff, Jr 3
Early research (Phase 1)WithdrawnNCT02427581
What this trial is testing

Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

Who this might be right for
Triple Negative Breast CancerTriple Negative Breast NeoplasmsTriple-Negative Breast Cancer
Washington University School of Medicine
Large-scale testing (Phase 3)Study completedNCT00456807
What this trial is testing

Complementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 100
Testing effectiveness (Phase 2)Study completedNCT00257465
What this trial is testing

Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma

Who this might be right for
Melanoma
AVAX Technologies 82
Load More Results